Healthcare M&A Advisory
Healthcare M&A Advisory. Price the Business That Actually Exists.
Buy-side and sell-side transaction support for physician groups and provider businesses, built around the things that genuinely move healthcare value: payer mix, collections, provider dependency, and compliance.
Quick Answer
What is healthcare M&A advisory?
Healthcare M&A advisory is financial and transaction support for buying or selling healthcare businesses such as physician groups, specialty practices, and provider-adjacent companies. It covers quality of earnings, payer mix and contract analysis, revenue cycle diligence, valuation, deal structuring, and post-close integration. It differs from general M&A because payer economics, provider retention, and regulatory compliance drive value more than headline revenue.
Key Takeaways
- Payer mix, contracted rates, and net collection rate matter more than gross billings.
- Provider dependency and retention is usually the largest single risk to post-close earnings.
- Coding and compliance history can change both price and deal structure.
- Sell-side value is created roughly 24 months before the process starts.
Last reviewed by the Sataurius advisory team.
Where Healthcare Deals Actually Break
Healthcare transactions rarely fail on price. They fail on assumptions that were never tested: a payer contract that renews at a lower rate, a retiring physician who took a third of the referral base with them, a coding pattern that will not survive an audit, or collections that were always weaker than gross charges implied.
Diligence in this sector is a clinical-operational exercise as much as a financial one. If the analysis stops at the income statement, the buyer is pricing a business that does not exist.
Buy-Side Support
- Quality of earnings, with healthcare-specific normalisations for owner compensation, provider ramp, and payer settlements.
- Payer mix and contract analysis, including rate benchmarking and renewal exposure.
- Revenue cycle review: net collection rate, denial patterns, days in AR, and the durability of reported revenue.
- Provider dependency and retention risk, modelled against post-close earnings.
- Compliance and coding risk assessment ahead of the letter of intent.
- Working capital peg, deal modelling, and integration planning.
Our buy-side diligence guide sets out what to complete before signing an LOI, and the 90-day integration playbook covers what happens after close.
Sell-Side Preparation
Sell-side value is created before the process starts, not during negotiation. We work backwards from what a private equity or strategic buyer will test, and resolve those issues while there is still time for the improvement to appear in the financials.
That typically means normalising and documenting EBITDA, reducing single-provider and single-referral concentration, tightening revenue cycle performance, cleaning up compliance, and building a data room that does not invite discounting. The sell a medical practice page walks through the full process, and the 24-month countdown covers the preparation timeline.
What's Included
Scope of Engagement
Quality of Earnings
Healthcare-specific EBITDA normalisation that tests whether reported earnings will repeat under new ownership.
Payer and Contract Analysis
Payer mix, contracted rates, renewal exposure, and the revenue concentration a buyer will price against.
Revenue Cycle Diligence
Net collection rate, denial patterns, and days in AR, to establish how much reported revenue is genuinely collectible.
Valuation and Deal Modelling
Adjusted EBITDA multiples, ancillary and real estate treatment, earn-outs, and rollover equity scenarios.
Provider Retention Risk
Compensation benchmarking and dependency analysis modelled directly into post-close earnings.
Post-Close Integration
A structured first-90-days financial plan covering systems, reporting cadence, and synergy tracking.
FAQ
Frequently Asked Questions
What is healthcare M&A advisory?
Healthcare M&A advisory is financial and transaction support for buying, selling, or merging healthcare businesses: physician groups, dental and specialty practices, behavioral health providers, ancillary services, and provider-adjacent companies. It covers quality of earnings, valuation, deal structuring, payer and referral risk analysis, and post-close integration.
How is healthcare M&A different from other transactions?
Three things change the analysis. Revenue is realised through payers rather than customers, so payer mix, contracted rates, and collection performance drive value more than headline billings. Provider compensation and retention are usually the largest single risk to post-close earnings. And regulatory exposure, including coding accuracy and compliance history, can materially alter both price and structure.
What is a quality of earnings analysis in a healthcare deal?
A quality of earnings analysis tests whether reported EBITDA is repeatable. In healthcare that means normalising owner compensation to market, examining collection rates against gross charges, testing for one-time payer settlements or grant income, adjusting for provider ramp and departures, and reviewing revenue recognised on claims that may not ultimately be paid.
How are physician practices valued in an acquisition?
Most practice transactions price off adjusted EBITDA multiples, with the multiple driven by size, specialty, payer mix, provider dependency, and growth. Ancillary revenue, real estate, and management infrastructure are often valued separately. Our medical practice valuation page covers the methods and value drivers in detail.
Do you represent buyers or sellers?
Both, on separate transactions. On the buy side we run diligence, model the deal, and price the risks we find. On the sell side we prepare the practice for scrutiny, resolve the issues a buyer would otherwise discount for, and support negotiation. We do not act for both parties on the same deal.
When should a practice owner start preparing for a sale?
Twenty-four months ahead of the intended exit is the point at which preparation still changes the price. That window allows time to improve documented EBITDA, reduce dependency on a single provider or referral source, clean up compliance and coding practice, and produce two full years of financial statements that survive diligence.
Related
Continue Exploring
Medical Practice Valuation
Valuation methods, EBITDA multiples by specialty, and the factors that move a practice's price.
Learn More →Sell a Medical Practice
The step-by-step sell-side process for physician owners, from preparation to close.
Learn More →Transaction Advisory Services
Our full due diligence, valuation, and deal support offering across all sectors.
Learn More →